Ryosuke Hiwa

612 total citations
37 papers, 212 citations indexed

About

Ryosuke Hiwa is a scholar working on Immunology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ryosuke Hiwa has authored 37 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Rheumatology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ryosuke Hiwa's work include Vasculitis and related conditions (11 papers), Systemic Lupus Erythematosus Research (6 papers) and T-cell and B-cell Immunology (6 papers). Ryosuke Hiwa is often cited by papers focused on Vasculitis and related conditions (11 papers), Systemic Lupus Erythematosus Research (6 papers) and T-cell and B-cell Immunology (6 papers). Ryosuke Hiwa collaborates with scholars based in Japan, United States and Czechia. Ryosuke Hiwa's co-authors include James L. Mueller, Julie Zikherman, Jeremy F. Brooks, Hailyn V. Nielsen, Vivasvan S. Vykunta, Corey Tan, Alexander Marson, Hajime Yoshifuji, Ran Nakashima and John Huizar and has published in prestigious journals such as Nature Communications, Nature Immunology and Scientific Reports.

In The Last Decade

Ryosuke Hiwa

31 papers receiving 212 citations

Peers

Countries citing papers authored by Ryosuke Hiwa

Since Specialization

Citations

This map shows the geographic impact of Ryosuke Hiwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Hiwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Hiwa more than expected).

Fields of papers citing papers by Ryosuke Hiwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Hiwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Hiwa. The network helps show where Ryosuke Hiwa may publish in the future.

Co-authorship network of co-authors of Ryosuke Hiwa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Hiwa. A scholar is included among the top collaborators of Ryosuke Hiwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Hiwa. Ryosuke Hiwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study 2025 ·Frontiers in Immunology ·(unknown), (unknown), Takuya Kotani, Keisuke Fukui, (unknown), Ryu Watanabe, Atsushi Manabe, (unknown), (unknown), Ryosuke Hiwa, Wataru Yamamoto, Motomu Hashimoto, Tohru Takeuchi	1
2	Anti-arthritic effects of polyunsaturated fatty acid–rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model 2025 ·Modern Rheumatology ·Akiko Yoshida, Kosaku Murakami, Hirotake Tsukamoto, (unknown), Yoichi Nakayama, Rintaro Saito, Mirei Shirakashi, Hideaki Tsuji, Ryosuke Hiwa, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Akira Ōnishi, Masao Tanaka, Tsuneyo Mimori, Akio Morinobu	1
3	Long‐term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA‐associated vasculitis in multicenter REVEAL cohort study 2025 ·Journal of Internal Medicine ·(unknown), Takuya Kotani, Daisuke Nishioka, (unknown), Yuichi Masuda, Tomoki Taniguchi, (unknown), (unknown), Ryosuke Hiwa, (unknown), Ryu Watanabe, Mochammad Hatta, Naoko Ito, (unknown), Hirofumi Miyake, Wataru Yamamoto, Motomu Hashimoto, Tohru Takeuchi	0
4	Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice 2025 ·Nature Communications ·Hailyn V. Nielsen, (unknown), James L. Mueller, (unknown), Ryosuke Hiwa, Irina Proekt, Elze Rackaityte, (unknown), (unknown), Christopher D. Scharer, Mark S. Anderson, Byron B. Au‐Yeung, Julie Zikherman	0
5	Fibrinogen induces inflammatory responses via the immune activating receptor LILRA2 2024 ·Frontiers in Immunology ·Yifan Li, Kouyuki Hirayasu, (unknown), Y. Tomita, (unknown), Ryosuke Hiwa, Hisashi Arase, Rikinari Hanayama	1
6	Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study 2024 ·Frontiers in Immunology ·(unknown), Ryu Watanabe, (unknown), Takuya Kotani, (unknown), Yuichi Masuda, (unknown), (unknown), (unknown), (unknown), Ryosuke Hiwa, Wataru Yamamoto, Akitoshi Takeda, Yoshiaki Itoh, Motomu Hashimoto	5
7	Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort study 2024 ·Arthritis Research & Therapy ·(unknown), Takuya Kotani, (unknown), Daisuke Nishioka, Yuichi Masuda, (unknown), Ryu Watanabe, Tomoki Taniguchi, Atsushi Manabe, (unknown), (unknown), Ryosuke Hiwa, Wataru Yamamoto, Motomu Hashimoto, Tohru Takeuchi	1
8	Avacopan’s potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis 2024 ·Modern Rheumatology Case Reports ·Tomoki Taniguchi, Ryosuke Hiwa, (unknown), (unknown), Mirei Shirakashi, Hideo Onizawa, Hideaki Tsuji, Koji Kitagori, Ran Nakashima, Shuji Akizuki, Akira Ōnishi, Hajime Yoshifuji, Masao Tanaka, Akio Morinobu	3
9	Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies 2024 ·Seminars in Arthritis and Rheumatism ·Hideaki Tsuji, Ran Nakashima, Takahiro Yasumi, (unknown), (unknown), Mirei Shirakashi, Hideo Onizawa, Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Akira Ōnishi, Hajime Yoshifuji, Masao Tanaka, Naoko Okiyama, Tsuneyo Mimori, Akio Morinobu	1
10	Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study 2024 ·Modern Rheumatology ·(unknown), Ryu Watanabe, (unknown), Takuya Kotani, (unknown), Yuichi Masuda, (unknown), (unknown), (unknown), (unknown), Ryosuke Hiwa, Wataru Yamamoto, Akitoshi Takeda, (unknown), Motomu Hashimoto	4
11	Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes 2023 ·Lara D. Veeken ·Akira Ōnishi, Hideaki Tsuji, (unknown), (unknown), Takeshi Iwasaki, (unknown), (unknown), Mirei Shirakashi, Hideo Onizawa, Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Masao Tanaka, Akio Morinobu	8
12	A case of atypical IgG4-related disease presenting hypereosinophilia, polyneuropathy, and liver dysfunction 2023 ·Modern Rheumatology Case Reports ·(unknown), Kosaku Murakami, Hideo Onizawa, Mirei Shirakashi, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Akira Ōnishi, Hajime Yoshifuji, Masao Tanaka, Akio Morinobu	0
13	Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort study 2023 ·Lara D. Veeken ·(unknown), Takuya Kotani, (unknown), Daisuke Nishioka, Ryu Watanabe, (unknown), Atsushi Manabe, (unknown), (unknown), Ryosuke Hiwa, Wataru Yamamoto, Motomu Hashimoto, Tohru Takeuchi	8
14	POS0142 THE ASSOCIATION OF AUTOANTIBODIES WITH CLINICAL MANIFESTATIONS AND LONG-TERM REMISSIONS IN COMPARISON WITH JUVENILE- AND ADULT-ONSET IDIOPATHIC INFLAMMATORY MYOPATHIES 2023 ·Hideaki Tsuji, Ran Nakashima, (unknown), Mirei Shirakashi, (unknown), Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, (unknown), Hajime Yoshifuji, Masao Tanaka, Takahiro Yasumi, Yuki Ichimura, Naoko Okiyama, Akio Morinobu	0
15	Long-Term Prognosis of Antimelanoma Differentiation–Associated Gene 5–Positive Dermatomyositis With Interstitial Lung Disease 2023 ·The Journal of Rheumatology ·(unknown), Ran Nakashima, Hideaki Tsuji, Toshiki Nakajima, Yoshitaka Imura, Yusuke Yoshida, Shintaro Hirata, Mirei Shirakashi, Ryosuke Hiwa, Koji Kitagori, (unknown), Hajime Yoshifuji, Tsuneyo Mimori, Akio Morinobu	5
16	NR4A nuclear receptors in T and B lymphocytes: Gatekeepers of immune tolerance* 2022 ·Immunological Reviews ·Ryosuke Hiwa, Jeremy F. Brooks, James L. Mueller, Hailyn V. Nielsen, Julie Zikherman	15
17	Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF 2022 ·Lara D. Veeken ·(unknown), Yuki Ishikawa, Takeshi Iwasaki, Ryosuke Hiwa, Keitaro Matsuo, Hiroh Saji, Kimiko Yurugi, Yasuo Miura, Moritoshi Furu, Hiromu Ito, Takao Fujii, Taira Maekawa, Motomu Hashimoto, Koichiro Ohmura, Tsuneyo Mimori, Chikashi Terao	1
18	Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus 2022 ·Lupus Science & Medicine ·(unknown), Hideaki Tsuji, Akira Ōnishi, (unknown), Mirei Shirakashi, Hideo Onizawa, Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Masao Tanaka, Hajime Yoshifuji, Akio Morinobu	9
19	NR4A family members regulate T cell tolerance to preserve immune homeostasis and suppress autoimmunity 2021 ·JCI Insight ·Ryosuke Hiwa, Hailyn V. Nielsen, James L. Mueller, Ravi Mandla, Julie Zikherman	20
20	NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting 2020 ·Nature Immunology ·Corey Tan, Ryosuke Hiwa, James L. Mueller, Vivasvan S. Vykunta, (unknown), Mark Noviski, John Huizar, Jeremy F. Brooks, (unknown), (unknown), Zhongmei Li, Alexander Marson, Julie Zikherman	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact